DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol.
White C, Wardill H, Paul C, Price T, Karapetis C, Nalder M, Burge ME, Thomas A, Oldmeadow C, Barker D, Edney LC, Coller J, Bowen J, Ostroff C, Cheek B, Carlson M, Rankmore T, Nagrial A, Clarke S, Chantrill L, Ackland S, Scott RJ.
White C, et al. Among authors: clarke s.
BMC Cancer. 2024 Nov 8;24(1):1369. doi: 10.1186/s12885-024-13122-8.
BMC Cancer. 2024.
PMID: 39516829
Free PMC article.